<DOC>
	<DOCNO>NCT01190566</DOCNO>
	<brief_summary>The purpose study : To validate efficacy multiparametric MRI , FDG-PET , RGD-PET , PET-MR fusion image prediction monitoring response neoadjuvant chemotherapy locally advance breast cancer patient . To identify optimal combination parameter MR spectroscopy , diffusion-weighted MRI , dynamic contrast-enhanced MRI , FDG-PET , RGD-PET prediction monitoring response neoadjuvant chemotherapy locally advance breast cancer patient . To compare performance dynamic contrast-enhanced MRI use parametric response map analysis versus pharmacokinetic parameter ( Ktrans , kep , Ve ) early prediction pathological responsiveness neoadjuvant chemotherapy breast cancer patient</brief_summary>
	<brief_title>PET-MR Prediction Monitoring Response Neoadjuvant Chemotherapy Breast Cancer</brief_title>
	<detailed_description>Enrolled woman breast cancer receive anthracycline-taxane regimen subsequent surgery prospectively enrol . DCE-MRI FDG-PET scan perform 1st cycle chemotherapy . MR image parameter SUV PET scan within tumor analyze . Clinicopathologic ( age , clinical tumor stage , hormonal receptor status , surgery type ) image parameter compare accord pathological response .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Pathologically confirm breast cancer Clinical stage IIb , IIIa , IIIb , IIIc Must measurable disease Performance status ECOG 02 Adequate , bone marrow , liver , heart , renal function Who receive chemotherapy breast cancer Must agree sign informed consent Prior history cancer besides breast cancer Active bacterial infection Pregnant lactate woman Psychological disease seizure History arrhythmia , congestive heart failure , myocardial infarct , unstable angina Male breast cancer Who pacemaker history open heart surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Magnetic Resonance Imaging , Functional</keyword>
	<keyword>Tomography , Positron-Emission</keyword>
	<keyword>chemotherapy</keyword>
</DOC>